semaglutide and tamoxifen JADPRO Clinical CYP2D6 Genotyping to Personalize
Description
Benefits for people with comorbidities: Doctors look at the whole health picture, not just weight or diabetes status
The study included a survey with 1,955 useable observations including 495 people who were currently taking a GLP-1, 468 who had previously taken one, 492 people who were planning to take one, and 500 people who were neither taking one nor planning to take one
The Precision Peptide Genetic Test examines key variants (GLP1R rs6923761, GIPR rs1800437, and others) that relate to how your body's natural GLP-1 signaling works
Fat mass reduction can potentially alter these hormonal pathways, though the net clinical effect varies among individuals
